|
|
|
Insider
Information: |
Jaen Juan C. |
Relationship: |
President |
City: |
Mountain View |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
371,475 |
|
Indirect Shares
|
1,188,233 |
|
|
Direct
Value |
$6,705,728 |
|
|
Indirect Value
|
$17,906,671 |
|
|
Total
Shares |
1,559,708 |
|
|
Total
Value |
$24,612,400 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
7
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
5
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-71.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Chemocentryx, Inc. |
CCXI |
SVP, Drug Discovery & ... |
2013-03-08 |
30,000 |
|
0 |
Premium* |
|
Arcus Biosciences Inc |
RCUS |
President |
2024-02-27 |
341,475 |
2024-02-27 |
1,188,233 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RCUS |
Arcus Biosciences Inc |
President |
|
2018-08-13 |
4 |
B |
$11.77 |
$37,168 |
I/I |
3,159 |
2,744,240 |
2.66 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2019-06-03 |
4 |
B |
$8.25 |
$82,485 |
I/I |
10,000 |
2,764,240 |
2.66 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2019-06-27 |
4 |
B |
$7.44 |
$75,217 |
I/I |
10,106 |
2,774,346 |
2.66 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2019-06-28 |
4 |
B |
$7.89 |
$38,637 |
I/I |
4,894 |
2,779,240 |
2.66 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2023-06-16 |
4 |
D |
$19.35 |
$93,267 |
D/D |
(4,820) |
313,862 |
0 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2023-12-18 |
4 |
D |
$17.74 |
$108,711 |
D/D |
(6,128) |
307,734 |
0 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2023-12-19 |
4 |
D |
$18.09 |
$113,225 |
D/D |
(6,259) |
301,475 |
0 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2020-10-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,207,000 |
1,572,240 |
0 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2022-02-28 |
4 |
GD |
$0.00 |
$0 |
I/I |
350,000 |
1,222,240 |
0 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2023-06-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
318,682 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSOOffic |
|
2012-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
75,000 |
|
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2012-12-17 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
55,500 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2012-12-18 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
55,500 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-02 |
4 |
OE |
$4.30 |
$25,030 |
D/D |
5,821 |
53,821 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-03 |
4 |
OE |
$4.30 |
$430 |
D/D |
100 |
53,100 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-04 |
4 |
OE |
$4.30 |
$413 |
D/D |
96 |
53,096 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-12 |
4 |
OE |
$4.30 |
$14,212 |
D/D |
3,305 |
56,305 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-22 |
4 |
OE |
$4.30 |
$430 |
D/D |
100 |
53,100 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-24 |
4 |
OE |
$4.30 |
$5,160 |
D/D |
1,200 |
54,200 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-25 |
4 |
OE |
$4.30 |
$413 |
D/D |
96 |
53,096 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-28 |
4 |
OE |
$4.30 |
$11,653 |
D/D |
2,710 |
53,928 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-29 |
4 |
OE |
$4.30 |
$21,036 |
D/D |
4,892 |
57,892 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-31 |
4 |
OE |
$4.30 |
$14,104 |
D/D |
3,280 |
54,600 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-01 |
4 |
OE |
$4.30 |
$28,918 |
D/D |
6,725 |
54,600 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-04 |
4 |
OE |
$4.30 |
$16,663 |
D/D |
3,875 |
56,100 |
0 |
- |
|
92 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|